Effects of inhaled nitric oxide on outcome after prolonged cardiac arrest in mild therapeutic hypothermia treated rats

• Published in: Scientific reports Vol. 8; no. 1; pp. 6743 - 9
• Main Authors: Brücken, Anne, Bleilevens, Christian, Berger, Philipp, Nolte, Kay, Gaisa, Nadine T., Rossaint, Rolf, Marx, Gernot, Derwall, Matthias, Fries, Michael
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 30.04.2018; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308/409; 692/700/1750; Cardiac arrest; Cerebral blood flow; Heart; Heart diseases; Humanities and Social Sciences; Hypothermia; Ischemia; Lactic acid; multidisciplinary; Neurological complications; Nitric oxide; Reperfusion; Rodents; Science; Science (multidisciplinary); Statistical analysis; Tumor necrosis factor-α
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-018-25213-1

Guidelines endorse targeted temperature management to reduce neurological sequelae and mortality after cardiac arrest (CA). Additional therapeutic approaches are lacking. Inhaled nitric oxide (iNO) given post systemic ischemia/reperfusion injury improves outcomes. Attenuated inflammation by iNO might be crucial in brain protection. iNO augmented mild therapeutic hypothermia (MTH) may improve outcome after CA exceeding the effect of MTH alone. Following ten minutes of CA and three minutes of cardiopulmonary resuscitation, 20 male Sprague-Dawley rats were randomized to receive MTH at 33 °C for 6hrs or MTH + 20ppm iNO for 5hrs; one group served as normothermic control. During the experiment blood was taken for biochemical evaluation. A neurological deficit score was calculated daily for seven days post CA. On day seven, brains and hearts were harvested for histological evaluation. Treatment groups showed a significant decrease in lactate levels six hours post resuscitation in comparison to controls. TNF-α release was significantly lower in MTH + iNO treated animals only at four hours post ROSC. While only the combination of MTH and iNO improved neurological function in a statistically significant manner in comparison to controls on days 4–7 after CA, there was no significant difference between groups treated with MTH and MTH + iNO.